OKYO Pharma OKYO
NASDAQ OKYO
$1.54 +0.04 (+2.67%)
At close: Aug 21, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Prepaid Assets (2023 - 2026)

OKYO Pharma (OKYO) posted quarterly Prepaid Assets of $205082.0 for Q1 2026, down 9.0% year-over-year from $225360.0 in Q1 2025, and down 48.0% quarter-over-quarter from $394367.0 in Q3 2025.

OKYO Pharma (OKYO) Prepaid Assets (2023 - 2026) Analysis & Trends

OKYO Pharma (OKYO) has reported Prepaid Assets for 4 consecutive years, with $205082.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets fell 9.0% year-over-year to $205082.0; the TTM figure through Mar 2026 stood at $205082.0 (down 9.0% YoY), while the FY2026 annual figure was $205082.0, down 9.0% from the prior year.
  • Prepaid Assets fell to $205082.0 in Q1 2026 per OKYO's latest filing, from $394367.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $394367.0 in Q3 2025 and bottomed at $130126.0 in Q1 2024.
  • Historically, Prepaid Assets has averaged $242738.3 across 4 years, with a median of $225360.0 in 2025.
  • Annual changes were most pronounced in 2024 — Prepaid Assets declined 24.01% — and 2025, when it surged 73.19%.
  • OKYO Pharma's Prepaid Assets stood at $253548.0 in 2023, then gained by 25.99% to $319437.0 in 2024, then grew by 23.46% to $394367.0 in 2025, then tumbled by 48.0% to $205082.0 in 2026.
  • Business Quant data shows OKYO's Prepaid Assets at $205082.0 in Q1 2026, $394367.0 in Q3 2025, and $225360.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 OKYO Pharma 1.52 Bn 1.52 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 205,082.00
Sep 30, 2025 394,367.00
Mar 31, 2025 225,360.00
Sep 30, 2024 319,437.00
Mar 31, 2024 130,126.00
Sep 30, 2023 253,548.00
Mar 31, 2023 171,248.00